HLX04 (bevacizumab biosimilar)
GPTKB entity
Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
biosimilar |
| gptkbp:approvedBy |
gptkb:China
|
| gptkbp:ATCCode |
L01XC07
|
| gptkbp:biosimilar |
gptkb:bevacizumab
|
| gptkbp:developedBy |
Henlius
|
| https://www.w3.org/2000/01/rdf-schema#label |
HLX04 (bevacizumab biosimilar)
|
| gptkbp:indication |
gptkb:non-small_cell_lung_cancer
colorectal cancer |
| gptkbp:mechanismOfAction |
VEGF inhibitor
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:bfsParent |
gptkb:Shanghai_Henlius_Biotech
|
| gptkbp:bfsLayer |
7
|